Good Evening Market Enthusiast,
Â
Every once in a while, a name comes along that refuses to fade quietly.
This one already carved out one of the biggest runs we’ve ever tracked—a move north of +300% when momentum was on its side.
Â
2025 has been no different: multiple intraday surges of 24%, 17%, 13%, 11%, and 10% prove the setup is still alive
and kicking. Momentum memory matters, and this ticker has it baked in.
Â
Now the stage is resetting.
The floor is defined. The upside levels are clear.
And in just the past few weeks, two powerful updates dropped that could shift the entire conversation.
Â
We’re talking about:
🔬 A fresh peer-reviewed publication validating its science
🌍 Selection at a world-class oncology conference with global eyes
watching
⚡ A Fast Track designation that opens the door to accelerated FDA timelines
Â
Layer that on top of a math gap you could drive a truck through (assets vs. valuation), plus insiders adding six-figure positions… and the timing couldn’t be sharper.
Â
Tomorrow morning at 8AM EST, I’ll reveal exactly who is back in focus.🔎
Â
If history is any guide, you won’t want to miss
it.
Â
Stay tuned,
Â
Max Masters
Co-founder, Market Tips Newsletter
Â